Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
Mahesh Tambe(University of Helsinki), Caroline A. Heckman(University of Helsinki)
Cited by 9
Related Papers
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
|Haematologica|2019|184
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML
|Blood|2017|122
The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis
|Cancer Research|2008|117